Rimmer Ryan A, Graf Alexander E, Fastenberg Judd H, Bilyk Jurij, Nyquist Gurston G, Rosen Marc R, Rabinowitz Michael P, Rabinowitz Mindy R
Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.
Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania.
Allergy Rhinol (Providence). 2020 Jan 14;11:2152656719899922. doi: 10.1177/2152656719899922. eCollection 2020 Jan-Dec.
The endoscopic endonasal approach to management of orbital pathology has expanded. Due to the rarity of these conditions, most reports in the literature consist of small case reports. We report a series from a single institution with a focus on outcomes.
A retrospective chart review was carried out between 2010 and 2018.
Twenty-four patients were identified (average age 58 years, 15 males, 9 females). Average follow-up was 14.9 months. Most common etiologies included cavernous hemangioma (7), metastases (6), idiopathic orbital inflammatory syndrome (6), orbital hematoma/clot (2), and schwannoma (1). Most common presenting symptoms were decreased visual acuity (8), proptosis (8), diplopia (7), and incidental findings (2). All patients underwent endoscopic medial wall orbital decompressions. Sixteen involved a combined open approach by an ophthalmologist. Pathology was either biopsied (15), resected (6), or could not be identified (3). No intraoperative complications were noted. No patients underwent orbital reconstruction of the medial wall. Six patients developed postoperative sinusitis successfully managed with antibiotics. One patient developed epistaxis managed conservatively. In 5 patients, Sino-Nasal Outcome Test-22 scores increased immediately postop and then decreased, whereas scores only decreased in 6 patients. Six patients noted reduced proptosis. There were no new cases of diplopia or worsening visual acuity.
A combined endoscopic endonasal and external approach can be useful for managing orbital lesions. Patients tolerated the procedure well with improvement in ocular symptoms and minimal sinonasal complications. Reconstruction of the medial wall may not be warranted to prevent postoperative diplopia.
鼻内镜经鼻入路治疗眼眶疾病的应用范围有所扩大。由于这些病症较为罕见,文献中的大多数报告均为小病例报告。我们报告了来自单一机构的一系列病例,并重点关注治疗结果。
对2010年至2018年期间的病历进行回顾性分析。
共纳入24例患者(平均年龄58岁,男性15例,女性9例)。平均随访时间为14.9个月。最常见的病因包括海绵状血管瘤(7例)、转移瘤(6例)、特发性眼眶炎性综合征(6例)、眼眶血肿/血凝块(2例)和神经鞘瘤(1例)。最常见的首发症状为视力下降(8例)、眼球突出(8例)、复视(7例)和偶然发现(2例)。所有患者均接受了鼻内镜下眶内侧壁减压术。16例患者联合眼科医生采用开放入路。病理检查结果为活检(15例)、切除(6例)或无法明确(3例)。术中未出现并发症。没有患者进行眶内侧壁重建。6例患者发生术后鼻窦炎,经抗生素治疗成功控制。1例患者发生鼻出血,采用保守治疗。5例患者的鼻窦结局测试-22评分在术后立即升高,随后下降,而6例患者的评分仅下降。6例患者的眼球突出减轻。没有出现新的复视病例或视力恶化情况。
鼻内镜经鼻联合外入路可用于治疗眼眶病变。患者对该手术耐受性良好,眼部症状得到改善,鼻窦并发症极少。眶内侧壁重建可能并非预防术后复视所必需。